FERRI, Clodoveo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 57.567
EU - Europa 28.223
AS - Asia 23.419
SA - Sud America 2.723
Continente sconosciuto - Info sul continente non disponibili 791
AF - Africa 443
OC - Oceania 47
Totale 113.213
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 56.663
GB - Regno Unito 10.015
IT - Italia 7.907
SG - Singapore 6.783
CN - Cina 6.388
HK - Hong Kong 3.023
BR - Brasile 2.083
SE - Svezia 1.969
VN - Vietnam 1.768
DE - Germania 1.627
FI - Finlandia 1.492
UA - Ucraina 1.437
TR - Turchia 1.420
FR - Francia 1.278
BD - Bangladesh 1.248
RU - Federazione Russa 852
KR - Corea 690
IN - India 565
BG - Bulgaria 504
CA - Canada 440
ID - Indonesia 284
NL - Olanda 250
MX - Messico 234
JP - Giappone 230
AR - Argentina 221
IE - Irlanda 204
ZA - Sudafrica 157
IQ - Iraq 137
PL - Polonia 124
AE - Emirati Arabi Uniti 119
EC - Ecuador 110
PK - Pakistan 106
MY - Malesia 99
ES - Italia 87
CO - Colombia 80
CL - Cile 75
BE - Belgio 68
BZ - Belize 67
IR - Iran 67
SA - Arabia Saudita 61
PH - Filippine 58
MA - Marocco 57
RO - Romania 57
AT - Austria 53
EG - Egitto 53
UZ - Uzbekistan 53
VE - Venezuela 50
LT - Lituania 43
NP - Nepal 38
TH - Thailandia 38
TN - Tunisia 38
AU - Australia 37
CH - Svizzera 37
TW - Taiwan 36
JO - Giordania 35
EU - Europa 34
PY - Paraguay 33
PE - Perù 29
AZ - Azerbaigian 27
JM - Giamaica 27
PT - Portogallo 27
KE - Kenya 26
IL - Israele 25
CZ - Repubblica Ceca 24
OM - Oman 21
TT - Trinidad e Tobago 21
BO - Bolivia 20
CR - Costa Rica 20
UY - Uruguay 19
HU - Ungheria 18
DZ - Algeria 17
GR - Grecia 17
HN - Honduras 16
BY - Bielorussia 15
DO - Repubblica Dominicana 15
KG - Kirghizistan 15
AL - Albania 14
KZ - Kazakistan 14
LV - Lettonia 14
ET - Etiopia 13
PA - Panama 13
PS - Palestinian Territory 13
DK - Danimarca 12
NO - Norvegia 12
SN - Senegal 11
GT - Guatemala 10
NI - Nicaragua 10
CI - Costa d'Avorio 9
LU - Lussemburgo 9
RS - Serbia 9
SK - Slovacchia (Repubblica Slovacca) 9
SV - El Salvador 9
SY - Repubblica araba siriana 9
CY - Cipro 8
MD - Moldavia 8
BB - Barbados 7
LB - Libano 7
ML - Mali 7
NG - Nigeria 7
SC - Seychelles 7
Totale 112.322
Salva come PNG Salva come JPEG
Città #
Southend 7.726
Fairfield 5.010
Ashburn 4.466
Singapore 4.448
Santa Clara 4.288
Woodbridge 3.480
Hong Kong 2.979
Jacksonville 2.767
Houston 2.693
Chandler 2.065
Hefei 1.956
Ann Arbor 1.930
Seattle 1.801
Wilmington 1.791
Chicago 1.773
Dearborn 1.675
Cambridge 1.606
San Jose 1.556
Los Angeles 1.507
London 1.169
Beijing 1.131
Nyköping 1.083
Helsinki 1.033
Council Bluffs 1.011
The Dalles 854
Izmir 825
Salt Lake City 772
Milan 699
Modena 633
New York 616
Seoul 581
Ho Chi Minh City 550
San Diego 528
Princeton 525
Rome 504
Sofia 491
Eugene 448
Hanoi 443
Lauterbourg 399
Tampa 378
Dallas 356
Buffalo 343
Elk Grove Village 336
Des Moines 260
Columbus 256
Moscow 250
Atlanta 227
Shanghai 226
Jakarta 202
São Paulo 196
Frankfurt am Main 180
Redwood City 180
Dublin 174
Bremen 170
Sterling 168
Bologna 159
Lancaster 154
Naples 146
Tokyo 138
Phoenix 130
Guangzhou 129
Florence 125
Boardman 124
Palermo 118
Toronto 115
Miami 111
Norwalk 110
Orem 110
Dulles 103
Turin 103
Detroit 100
Falls Church 94
Delhi 92
Mexico City 91
Bari 89
Istanbul 89
Denver 87
Montreal 85
Genoa 82
Catania 81
New Delhi 81
Warsaw 80
Da Nang 79
Haiphong 75
North Bergen 75
Verona 74
Brooklyn 73
Miano 73
Munich 72
Nanjing 71
Kansas City 70
Johannesburg 68
Belize City 67
Chennai 65
San Francisco 63
Belo Horizonte 56
Dong Ket 56
Jinan 56
Manchester 56
Pittsburgh 55
Totale 77.844
Salva come PNG Salva come JPEG
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.870
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 966
La capillaroscopia in reumatologia. Lesioni elementari e metodi di scoring 803
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 786
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia 763
Semeiotica dell'articolazione temporo-mandibolare 563
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 487
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 464
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 449
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 444
B-cells and mixed cryoglobulinemia 444
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 443
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. 438
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 427
Validation of the classification criteria for cryoglobulinaemic vasculitis 396
Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients 393
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 392
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 392
Endocrine manifestations of hepatitis C virus infection. 389
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 387
Thymus alterations and systemic sclerosis 385
Heart involvement and systemic sclerosis 381
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus 376
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 374
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 374
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature 373
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 371
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. 369
Systemic sclerosis in childhood - Clinical and immunologic features of 153 patients in an international database 363
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides 363
High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis 361
Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures 359
Current treatment of hepatitis C-associated rheumatic diseases. 359
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 358
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 358
Cardiac Involvement in Systemic Vasculitis 354
Extrahepatic manifestations of Hepatitis C Virus infection: A general overview and guidelines for a clinical approach 351
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 350
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 349
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 347
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 347
Scleroderma digital ulcers complicated by infection with fecal pathogens. 346
Cardiac involvement in systemic sclerosis: identification of high-risk patient profiles in different patterns of clinical presentation 345
Aortic pulse wave velocity measurement in systemic sclerosis patients. 344
CXCL10 and CCL2 serum levels in patients with mixed cryoglobulinaemia and hepatitis C. 343
Elevated Troponin Serum Levels in Adult Onset Still's Disease 342
Correlation of articular involvement, skin disfigurement, and unemployment with depressive symptoms in patients with systemic sclerosis: a hospital sample 341
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 341
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 340
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 340
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 339
Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus. 335
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis 335
Cytomegalovirus-associated cutaneous vasculopathy and scleroderma sans inclusion body change 334
Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity 334
Cytokines and HCV-related disorders 333
Clinical and subclinical autoimmune thyroid disorders insystemic sclerosis 332
Thyroid involvement in patients with HCV-related mixed cryoglobulinaemia 330
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 328
Efficacy of Belimumab for active lupus nephritis in a young Hispanic woman intolerant to standard treatment: a case report 328
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C. 327
Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report. 327
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 327
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 326
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 325
L-Arginine in pregnant scleroderma patients 325
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 324
Associations between Systemic Sclerosis and Thyroid Diseases 324
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 322
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis 321
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 319
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 319
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 318
SAT0633-HPR Articular Involvement of the Scleroderma Hand: An Assessment Protocol for Planning Occupational Therapy Strategies 317
High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia 316
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 316
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 316
Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma 312
Platelet gel in the treatment of severe scleroderma skin ulcers. 312
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 311
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 311
The A, B, Cs of viral hepatitis in the biologic era. 310
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 310
Non HCV-related mixed cryoglobulinemia 309
Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role. 308
Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 308
High circulating levels of N-terminal pro-brain natriuretic peptide and interleukin 6 in patients with mixed cryoglobulinemia 307
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 303
Large Vessel Vasculitis Occurring in Rheumatoid Arthritis Patient under Anti-TNF Therapy 302
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry. 301
Interstitial lung fibrosis and rheumatic disorders in patients with hepatitis C virus infection. 300
Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia 300
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 298
HCV and cryoglobulinemic vasculitis. 296
N-Terminal Pro-Brain Natriuretic Peptide and Tumor Necrosis Factor-alpha Both Are Increased in Patients With Hepatitis C 295
Successful treatment with leflunomide of arthritis in systemic sclerosis patients 295
Insights into the knowledge of complex diseases: Environmental infectious/ toxic agents as potential etiopathogenetic factors of systemic sclerosis 294
CXCL10 and CCL2 Chemokine Serum Levels in Patients With Hepatitis C Associated With Autoimmune Thyroiditis 293
GISEA: an Italian biological agents registry in rheumatology 293
Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines 292
Totale 40.157
Salva come PNG Salva come JPEG
Categoria #
all - tutte 448.073
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 448.073
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227.690 0 961 816 688 225 438 427 430 891 607 1.239 968
2022/20237.691 1.000 615 410 558 962 1.174 370 689 963 183 469 298
2023/20246.193 242 364 373 611 1.307 501 594 655 145 384 413 604
2024/202516.486 663 224 296 1.315 3.092 2.336 829 931 1.887 1.376 1.659 1.878
2025/202634.940 1.667 1.205 2.541 4.677 7.266 2.616 3.613 1.479 2.666 2.719 2.408 2.083
2026/20271.472 1.344 128 0 0 0 0 0 0 0 0 0 0
Totale 113.213